Skip to main content
SpringerLink
Log in

Screening procedure for women at risk of developing postmenopausal osteoporosis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

The present study includes 70 healthy, immediately postmenopausal women stratified according to future rate of bone loss. The stratification was performed by means of four parameters of bone turnover: serum alkaline phosphatase, fasting urinary calcium and hydroxyproline, and body weight, used in an equation developed in a previous study. After the stratification the women were followed without intervention for the next 24 months, with bone mass measurements every 3 months. The bone loss estimated at baseline by means of the equation correlated with the bone loss measured in the forearm (y=0.72x−1.52;r=0.61;P<0.001). Plasma bone gla protein (BGP, osteocalcin), which is a new specific marker of bone formation, was now added to the model (replacing body weight). This increased the diagnostic validity (y=x;r=0.76;P<0.001). From the present study we conclude that the postmenopausal bone loss can be predicted by means of four biochemical parameters determined in plasma and urine in women just after the menopause.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cummings ST, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 1985; 7: 178–208.

    PubMed  Google Scholar 

  2. Hui SL, Slemenda CW, Johnston C, Appledorn CR. Effects of age and menopause on vertebral bone density. Bone Miner 1987; 2: 141–6.

    PubMed  Google Scholar 

  3. Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987; 65: 697–702.

    PubMed  Google Scholar 

  4. Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 1987; 316: 173–7.

    PubMed  Google Scholar 

  5. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273–9.

    PubMed  Google Scholar 

  6. Lindsay R, Aitken JM, Anderson JB et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; i: 1038–40.

    Google Scholar 

  7. Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i: 459–61.

    Google Scholar 

  8. Mack TM, Pike MC, Henderson BE et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262–7.

    PubMed  Google Scholar 

  9. Persson I, Adami H-O, Bergkvist L et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br Med J 1989; 298: 147–151.

    Google Scholar 

  10. Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560–3.

    PubMed  Google Scholar 

  11. Reginster JY, Albert A, Lecart MP et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; ii: 1481–3.

    Google Scholar 

  12. Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299: 477–9.

    Google Scholar 

  13. Ott SM, Kilcoyne RF, Chesnut III CH. Longitudinal changes in bone mass after one year as measured by different techniques in patients with osteoporosis. Calcif Tissue Int 1986; 39: 133–8.

    PubMed  Google Scholar 

  14. Riis BJ, Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646–53.

    PubMed  Google Scholar 

  15. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: An indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18: 191–5.

    PubMed  Google Scholar 

  16. Christiansen C, Riis BJ, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–8.

    Google Scholar 

  17. Christiansen C. Selection of postmenopausal women for estrogen therapy. In: Christiansen C, Johansen J, Riis BJ, eds. Osteoporosis 1987. Proceedings of the international symposium on osteoporosis, Denmark 1987. Copenhagen: Osteopress, ApS, 1987; 533–8.

    Google Scholar 

  18. Nilas L, Borg J, Gotfredsen A, Christiansen C. Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med 1985; 26: 1257–62.

    PubMed  Google Scholar 

  19. Nilas L, Hassager C, Christiansen C. Long-term precision of dual-photon absorptiometry in the lumbar spine in clinical settings. Bone Miner 1988; 3: 305–15.

    PubMed  Google Scholar 

  20. Gotfredsen A, Borg J, Christiansen C, Mazess RB. Total body bone mineral in vivo by dual-photon absorptiometry. I. Measurement procedures. Clin Physiol 1984; 4: 343–55.

    PubMed  Google Scholar 

  21. Boddy K, King PC, Hume R, Weyers E. The relation of total body potassium to height, weight, and age in normal adults. J Clin Pathol 1972; 25: 512–7.

    PubMed  Google Scholar 

  22. Hassager C, Gotfredsen A, Jensen J, Christiansen C. Prediction of body composition by age, height, weight, and skinfold thickness in normal adults. Metabolism 1986; 35: 1081–4.

    PubMed  Google Scholar 

  23. Johansen JS, Hansen JEM, Christiansen C. A radioimmunoassay for bone gla-protein (BGP) in human plasma. Acta Endocrinol 1987; 114: 410–6.

    PubMed  Google Scholar 

  24. Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984; 142: 145–8.

    PubMed  Google Scholar 

  25. Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass. J Clin Invest 1987; 80: 1261–9.

    PubMed  Google Scholar 

  26. Civitelli R, Gonnelli S, Zacchei F et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74.

    PubMed  Google Scholar 

  27. Ross PD, Wasnich RD, Vogel JM. Precision error in dual-photon absorptiometry related to source age. Radiology 1988; 166: 523–7.

    PubMed  Google Scholar 

  28. Riis BJ, Rødbro P, Christiansen C. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis. Calcif Tissue Int 1986; 38: 318–22.

    PubMed  Google Scholar 

  29. Riggs BL, Mann KG. Assessment of bone turnover in osteoporosis using biochemical markers. In: Christiansen C, Johansen JK, Riis BJ, eds. Osteoporosis 1987. Proceedings of the international symposium on osteoporosis, Denmark 1987. Copenhagen: Osteopress ApS, 1987; 672–6.

    Google Scholar 

  30. Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C. Bone turnover in spinal osteoporosis. J Bone Min Res 2: 497–503.

  31. Jensen GF, Christiansen C, Transbøl I. Fracture frequency and bone preservation in postmenopausal women treated with oestrogen. Obstet Gynecol 1982; 60: 493–6.

    PubMed  Google Scholar 

  32. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. I. A 10-year prospective study in the releationship to osteoporosis. Obstet Gynecol 1979; 53: 277–81.

    PubMed  Google Scholar 

  33. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–4.

    Google Scholar 

  34. Delmas PD, Christiansen C, Mann KG, Price PA. Bone gla-protein (osteocalcin) assay standardization report. J Bone Min Res 1990; 5: 5–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Chemistry, Glostrup Hospital, University of Copenhagen, DK-2600, Glostrup, Denmark

    C. Christiansen & B. J. Riis

  2. Department of Clinical Psychology, Aalborg Hospital, Denmark

    P. Rødbro

Authors
  1. C. Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Riis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Rødbro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christiansen, C., Riis, B.J. & Rødbro, P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1, 35–40 (1990). https://doi.org/10.1007/BF01880414

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01880414

Keywords

Search

Navigation